Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease

被引:0
作者
Ronglin Wang
Fangfang Lu
Gang Zhu
Dayun Feng
Tiejian Nie
Kai Tao
Shaosong Yang
Jie Lei
Lu Huang
Zixu Mao
Qian Yang
机构
[1] The Fourth Military Medical University,Department of Neurosurgery, Tangdu Hospital
[2] Emory University School of Medicine,Departments of Pharmacology and Neurology
[3] GuangZhou Medical University,Department of Neurology
来源
Cell Death & Disease | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
MiRNAs, a group of powerful modulator of gene expression, participate in multiple cellular processes under physiological and pathological conditions. Emerging evidence shows that Drosha, which controls the initial step in canonical miRNA biogenesis, is involved in modulating cell survival and death in models of several diseases. However, the role of Drosha in Parkinson’s disease (PD) has not been well established. Here, we show that the level of Drosha decreases in 6-OHDA-induced cellular and animal models of PD. 6-OHDA induced a p38 MAPK-dependent phosphorylation of Drosha. This triggered Drosha degradation. Enhancing the level of Drosha protected the dopaminergic (DA) neurons from 6-OHDA-induced toxicity in both in vitro and in vivo models of PD and alleviated the motor deficits of PD mice. These findings reveal that Drosha plays a critical role in the survival of DA neurons and suggest that stress-induced destabilization of Drosha may be part of the pathological process in PD.
引用
收藏
相关论文
共 50 条
[31]   Low doses of dexamethasone suppress dopaminergic neuron loss by modulating microglial functions in a rat model of Parkinson's disease [J].
Wada, Aiko ;
Sugimoto, Kana ;
Higaki, Hiromi ;
Takahashi, Hisaaki ;
Yano, Hajime ;
Tanaka, Junya .
JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 :S277-S277
[32]   Selective inhibition of NF-kB activation prevents the loss of dopaminergic neuron in the mouse model of Parkinson's disease [J].
Ghosh, A. ;
Ray, A. ;
Liu, X. ;
Pahan, K. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 :266-266
[33]   Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease [J].
Pereira, Carolina Parga Martins ;
Francis-Oliveira, Jose ;
Singulani, Monique Patricio ;
Ferreira, Ana Flavia Fernandes ;
Britto, Luiz Roberto G. .
JOURNAL OF NEUROIMMUNOLOGY, 2023, 375
[34]   Oxidative stress to dopaminergic neurons as models of Parkinson's disease [J].
Gille, G ;
Hung, ST ;
Reichmann, H ;
Rausch, WD .
STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 :533-540
[35]   PUERARIN PROTECTS DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE MODELS [J].
Zhang, X. ;
Xiong, J. ;
Liu, S. ;
Wang, L. ;
Huang, J. ;
Liu, L. ;
Yang, J. ;
Zhang, G. ;
Guo, K. ;
Zhang, Z. ;
Wu, P. ;
Wang, D. ;
Lin, Z. ;
Xiong, N. ;
Wang, T. .
NEUROSCIENCE, 2014, 280 :88-98
[36]   Parkinson's disease: animal models and dopaminergic cell vulnerability [J].
Blesa, Javier ;
Przedborski, Serge .
FRONTIERS IN NEUROANATOMY, 2014, 8
[37]   Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease [J].
Yao, Ning ;
Wu, Yanhong ;
Zhou, Yan ;
Ju, Lili ;
Liu, Yujun ;
Ju, Rongkai ;
Duan, Deyi ;
Xu, Qunyuan .
BRAIN RESEARCH, 2015, 1625 :255-274
[38]   CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease [J].
Smith, PD ;
O'Hare, MJ ;
Park, DS .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (09) :445-451
[39]   Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease [J].
Trinh, Kien ;
Moore, Katherine ;
Wes, Paul D. ;
Muchowski, Paul J. ;
Dey, Joyoti ;
Andrews, Laurie ;
Pallanck, Leo J. .
JOURNAL OF NEUROSCIENCE, 2008, 28 (02) :465-472
[40]   Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter [J].
Hartmann, A ;
Hunot, S ;
Hirsch, EC .
EXPERIMENTAL NEUROLOGY, 2003, 184 (02) :561-564